Xconomy Boston

Dyax Names Christensen New CEO; Blair Retiring

Luke Timmerman10/20/08

Dyax, the Cambridge, MA-based drug developer, said today that Gustav Christensen will replace co-founder Henry Blair as president and CEO on Jan. 1. Christensen joined the company as chief business officer in April 2007. Blair, who co-founded the company in 1989, plans to retire as CEO but remain chairman of the board at Dyax.

Luke Timmerman is the National Biotech Editor of Xconomy, and the Editor of Xconomy Seattle. E-mail him at ltimmerman@xconomy.com or follow him on Twitter at twitter.com/ldtimmerman.

Next Post

Related Topics

Related Posts

Add Your Thoughts

You will have 10 minutes to edit your post after you press publish.

Comments may be edited for clarity and length, rejected, or deleted.
By clicking "Publish," you are agreeing to these Terms and Conditions.

    

Xconomy Events

Xconomy Forum: New England’s Emerging Biotech Stars

Register or Learn More

Xconomy’s Most Popular

  1. The 10 Social News Apps You Need to Try
  2. 7 Lessons from TechStars’ David Cohen on Building a Startup Culture
  3. Q4 Venture Deals, Dollars Stayed Strong, Making 2011 Best in a Decade
  4. With TV App, Dijit Hopes to Ride Out the Coming Apple Revolution in TV
  5. 10 Apps & Sites That Bring Back the Joy of Reading

Xconomy on Demand

Did you miss something? Don't despair…

Xconomy offers a number of ways to subscribe for free!

Subscribe Now
IDG Tech Network
Protected by Mozy
Eventbrite - events made easy

Business, life sciences, and technology news — covering Boston, Seattle, San Diego, Detroit, San Francisco, New York and beyond.

© 2007-2012, Xconomy, Inc. Xconomy is a registered service mark of Xconomy, Inc. All rights reserved.

Site produced by Andrew Koyfman with design from Rob Hunter.